Orchestra BioMed founded in 2017 out of New Hope, Penn. is a biomedical company that brings high-impact medical technology to patients through collaboration and risk-reward partnerships, according to a June 29 press release.
Three takeaways from the collaboration:
- Orchestra BioMed and Medtronic will partner to develop a potential treatment for patients with hypertension who have a cardiac pacemaker.
- The $110 million in financing is managed by RTW Investments, Perspective Advisors, Terumo, SternAegis Ventures and others.
- Orchestra BioMed now has enough capital that it expects to be able to fund operations into 2026.
Latest articles on healthcare information technology:
Graphite Health hires Baylor Scott & White Health’s chief legal officer
16 recent health IT innovations, partnerships
Tampa General Hospital launches home-based healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
